DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Industry in the United States 2018" report has been added to ResearchAndMarkets.com's offering.
The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide.
The industry has undergone dramatic structural changes over the past few decades, with the rise of the biotechnology sector, substantial growth in demand driven by demographics and substitution away from other therapeutic modalities such as surgery, and increased competition from globally active generic manufacturers.
The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs in the United States. Drug expenditures are now the fastest-growing component of healthcare costs, increasing at the rate of about 15 percent per year.
The report brings you a complete analysis of the Pharmaceutical Industry in the United States 2018. The report covers a brief profile of the global pharmaceutical industry, an analysis of the US pharmaceutical industry, the US generic drugs industry and the US OTC pharmaceutical industry as well.
The report also analyzes the US pharmaceutical industry through two frameworks - a PEST analysis and a Porter's Five Forces Business Strategy analysis. The report also looks at strategies for market entry, and the role of the government in the industry.
Major players in the industry are analyzed through an analysis of their business segments, a financial analysis and an in-depth SWOT analysis.
- Allergan Plc
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Mylan NV
- Pfizer Inc.
- Teva Pharmaceutical Industries Limited
- Sandoz International GmbH
Key Topics Covered
A. Executive Summary
B. Global Pharmaceutical Industry
C. Analyzing the Pharmaceutical Industry in the US
D. Analyzing the US Generics Industry
E. Analyzing the US OTC Pharmaceutical Industry
F. US Pharmaceutical Industry: Porter's Five Forces Strategy Analysis
G. US Pharmaceutical Industry: PEST Framework Analysis
H. International Competition and Economic Trends in the US Pharma Industry
I. Key Trends in the Pharmaceutical Sector Supply Chain
J. Market Trends & Challenges
K. Research and Development
L. Patents in the US Pharmaceutical Industry
M. Leading Players
For more information about this report visit https://www.researchandmarkets.com/research/kgjqnp/the?w=4